Livzon Pharmaceutical Group Inc.

符号: 000513.SZ

SHZ

38.98

CNY

今天的市场价格

18.4135
市盈率
0.4788
PEG比率
31.91B
MRK市值
0.04%
DIV收益率

Livzon Pharmaceutical Group Inc. (000513-SZ) 财务报表

Q: 什么是 Livzon Pharmaceutical Group Inc. (000513.SZ) 总资产是多少？

Livzon Pharmaceutical Group Inc. (000513.SZ) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Livzon Pharmaceutical Group Inc. (000513.SZ). 的默认数据。公司收入显示 4121.024 M 的平均值，即 0.105 % 增长率。整个期间的平均毛利润为 2439.281 M，即 0.139 %. 平均毛利率为 0.493 %. 公司去年的净收入增长率为 0.023 %，等于 0.699 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Livzon Pharmaceutical Group Inc. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.007. 在流动资产领域，000513.SZ 的报告货币为17266.175. 这些资产中的很大一部分，即 11407.516 是现金和短期投资。与去年的数据相比，该部分的变化率为0.084%. 公司的长期投资虽然不是其重点，但以报告货币计算的1680.87（如果有的话）为1680.87。这表明与上一报告期相比，3.113% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 1612.773. 这一数字表明，0.392% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 14042.495. 这方面的年同比变化率为 0.012%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为3648.366，存货估值为 2060.65，商誉估值为 124.91（如有. 无形资产总额（如果有）按 714.17 估值.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1992
balance-sheet.row.cash-and-short-term-investments	43995.67	11407.5	10519.4	9329.1	9979.7	8872.6	8603.9	7424.5	2067.9	804.9	722.1	772.4	1280.7	1492.1	921.8	637.4	662	730.8	421	200	418.6	484.5	312.2	248.8	120.7	152.5	44.9	76.3	90.3	42.8	62.1	51.4	80.1
balance-sheet.row.short-term-investments	333.39	81.8	108.1	182.8	26	17.2	15.9	8.7	6	6.6	6.4	11.3	59.3	44.3	57.9	48.9	121.8	448.1	137.1	70.5	115.1	60.5	16.9	16	10.7	0	0	0	1.3	5.7	11.2	0	0
balance-sheet.row.net-receivables	16280.25	3648.4	4285.6	3622.8	3108.6	2703.5	2630.3	2698.5	2113.9	1856.7	1648.4	1606.2	1199.8	1036	827.8	885.8	624.9	546.5	449.1	404.4	414.4	390.1	154.8	205.6	31.8	11.5	11.1	32.1	55.3	35	21.8	17.3	19.2
balance-sheet.row.inventory	8476.78	2060.7	2045.3	1663.2	1487.8	1168.9	1117	1102.6	1099.2	983.9	847.5	641.6	546.5	424.4	450.2	339.3	346.1	325.4	281.2	238.9	212.6	188	199.3	197.6	209.1	198.6	221	223.9	156.5	175.5	118.9	150.8	140
balance-sheet.row.other-current-assets	603.22	149.6	136.9	57.9	51.3	128.3	120.5	124.3	689.7	-67.6	-52.1	-39.5	-53	-44.5	-44.1	-20.9	-23.1	-16.6	5	0.9	0.1	0.5	309	259.8	433	460.7	535.9	474.8	438.8	356.5	300.4	298.6	202.1
balance-sheet.row.total-current-assets	69355.92	17266.2	16987.3	14673.1	14627.4	12873.2	12471.7	11349.9	5970.8	3577.9	3165.9	2980.7	2973.9	2908	2155.7	1841.6	1609.8	1586.1	1156.2	844.2	1045.8	1063.1	975.3	911.7	794.6	823.3	813	807.1	741	609.8	503.1	518	441.4
balance-sheet.row.property-plant-equipment-net	18589.52	4733.9	4591.9	4238.9	3707.1	3393.6	3402.1	3391.5	3542.7	3671.1	3505.4	3059.8	2157.7	1241.9	1147	928.1	963.3	1007.9	1037	1024.4	860.6	677.5	663.1	593.2	587.2	578.3	558.8	514.7	457.3	388.6	303.9	235.1	134.3
balance-sheet.row.goodwill	499.65	124.9	103	103	103	103	103	103	103	103	103	103	103	103	103	103	103	67.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	2867.53	714.2	826.4	834.8	487.8	378.1	325.3	289.1	313.7	272.7	258.3	224.5	206.6	171.9	168.1	153.6	158.4	156.1	136.9	117.3	122.4	108.3	109	73	58.4	36.7	28.5	8.1	5.7	4.5	3	0	0
balance-sheet.row.goodwill-and-intangible-assets	3367.17	839.1	929.4	937.8	590.9	481.1	428.4	392.2	416.8	375.8	361.3	327.6	309.7	274.9	271.1	256.7	261.4	223.3	136.9	117.3	122.4	108.3	109	73	58.4	36.7	28.5	8.1	5.7	4.5	3	0	0
balance-sheet.row.long-term-investments	6491.32	1680.9	1630.1	1512.1	962.1	634	579.9	277.4	232.4	241.9	172.8	122.5	72.3	83.4	-1.4	12.4	-70	-347.1	-81.6	-11.5	-72	8.6	44.2	32.7	66	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	1169.97	301.9	280.5	252.7	238.2	182.7	141.6	127.2	153.1	104.3	65.3	50.2	43.2	36	22.9	31.2	31.7	19.6	144.4	76.2	122.1	66.4	19.5	17.9	-39.9	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	1786.7	222.9	445.5	757.3	465.2	411.9	413.7	359.6	213.5	106.5	32	25.2	77.1	58.6	66.5	54.3	127.4	456	65.5	113	123.1	205.4	45.4	47.7	122	119.5	160.6	180.3	112.7	106.9	60.1	44.1	18.5
balance-sheet.row.total-non-current-assets	31404.69	7778.7	7877.5	7698.8	5963.5	5103.3	4965.6	4547.9	4558.5	4499.7	4136.7	3585.3	2659.9	1694.9	1506.3	1282.8	1314	1359.7	1302.2	1319.4	1156.1	1066.2	881.1	764.5	793.7	734.5	747.9	703	575.7	500	367	279.2	152.8
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	100760.61	25044.8	24864.8	22371.9	20590.8	17976.5	17437.3	15897.7	10529.3	8077.5	7302.6	6566	5633.8	4602.9	3662	3124.4	2923.8	2945.7	2458.4	2163.6	2201.9	2129.3	1856.4	1676.2	1588.3	1557.8	1560.9	1510.1	1316.7	1109.8	870.1	797.3	594.3
balance-sheet.row.account-payables	6268.61	763.8	1862	1817.3	1624.8	1263.1	1354.9	1163.5	911.5	935.8	951.4	811.7	595.4	207.9	164.7	182.4	159.5	181.6	185.3	159.3	258.2	134.1	228.4	112.1	141.8	96.4	94.4	125.3	93.3	121.3	43.4	53.7	31.7
balance-sheet.row.short-term-debt	9312.59	3414.3	1632.7	2052.3	1559.5	1360.8	1500.4	0.4	0.4	650.4	376.3	491.5	536.6	251.7	277.9	219	531.1	420.4	580.7	594.1	448.8	492.5	183.2	301.6	173.8	139.5	199.5	108.4	230.7	200.8	109.7	102.3	212.3
balance-sheet.row.tax-payables	920.92	181.6	255.5	160.4	248.8	223.3	245.1	1045.8	292.3	130	33.2	89.4	96.7	90.2	83.8	77.6	77.1	68.6	26.5	8	15.5	43.4	45.1	40.7	21.1	36.7	-0.3	14.9	26.2	16.2	15.8	4.1	2.7
balance-sheet.row.long-term-debt-total	7547.76	1612.8	1986.1	642.1	370.4	0	0.7	0.7	0.7	0.7	466.5	549.9	0.7	1.2	66.8	90.7	100.7	70.7	110.7	0.7	89.6	25	71.5	0.6	50.5	55.1	19.8	83.4	82.2	0.3	0.1	2.5	15.7
Deferred Revenue Non Current	1162.85	269.4	273.2	258.9	276.1	246.7	262.7	225.8	95	99.6	77.3	0	74.2	67.1	28.6	27.7	19.3	15.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	799.89	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	3949.21	3771	3675.8	13.5	6.3	151.8	2269.2	115.3	428.7	65.3	356	61.8	438	439	21.1	16.5	12.8	5	7.6	8.5	15.3	18.7	18.3	24.4	15.8	15.3	21	10.3	12.3	0.7	3	1.6	10
balance-sheet.row.total-non-current-liabilities	9610.15	1921.6	2531.9	1135.8	867.8	407.6	317.9	253.1	113	112.7	551	631.8	77.4	70.2	97.6	121.7	121.9	118.3	132.8	17.3	110.3	58.3	82.4	0.6	50.5	58.9	32.5	84.7	82.2	0.3	0.1	2.5	15.7
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	36.35	9	11.6	5.3	10.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	41566.98	10008.8	9928.6	8060.9	6950.7	5701.2	5687.5	4664.1	3423.6	3267.6	3220.2	2961.5	2453.6	1591.3	1022.8	898.9	1089.3	954.8	1079.9	925.2	1030	954.7	727.1	639.4	581.2	584	494.5	473.4	547.1	447.5	246.6	250.6	318.7
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	3721.69	923.9	935.6	937.9	944.8	934.8	719.1	553.2	425.7	396.9	295.7	295.7	295.7	295.7	295.7	295.7	306	306	306	306	306	306	306	306	306	306	306	306	199.4	199.4	184.4	162.9	113.1
balance-sheet.row.retained-earnings	43069.29	10908.2	10437.6	9716.4	8937.3	8419	8012.6	8028.3	3812.4	3267	2708	2352.1	2023.3	1740.6	1446.7	1114.7	711.2	817.3	267.8	153.5	118.5	70.8	16.2	19	50.8	39.2	97.6	84.3	58.4	5.5	115.7	79.5	59.2
balance-sheet.row.accumulated-other-comprehensive-income-loss	7190.87	1180.4	1136.4	982.7	1018.6	721.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	1722.63	1029.9	1366.4	1366.8	1206.5	1091.1	1920.3	2191.2	2267.8	682.3	692.8	696.8	688.9	806.8	775	738.7	761.3	819.3	765.7	744.8	715.2	667.7	627.2	594	559.2	556.8	615	603.8	480.7	452.2	318.2	304.3	103.2
balance-sheet.row.total-stockholders-equity	55704.48	14042.5	13876	13003.8	12107.2	11166.8	10652	10772.7	6506	4346.3	3696.5	3344.6	3008	2843.2	2517.4	2149.1	1778.5	1942.7	1339.5	1204.4	1139.7	1044.6	949.4	919	916	902	1018.6	994.2	738.5	657.1	618.3	546.7	275.6
balance-sheet.row.total-liabilities-and-stockholders-equity	100760.61	25044.8	24864.8	22371.9	20590.8	17976.5	17437.3	15897.7	10529.3	8077.5	7302.6	6566	5633.8	4602.9	3662	3124.4	2923.8	2945.7	2458.4	2163.6	2201.9	2129.3	1856.4	1676.2	1588.3	1557.8	1560.9	1510.1	1316.7	1109.8	870.1	797.3	594.3
balance-sheet.row.minority-interest	3219.79	724.2	1060.2	1307.3	1532.8	1108.5	1097.9	460.9	599.7	463.6	385.9	259.9	172.1	168.4	121.7	76.4	56	48.3	39	34.1	32.2	130	180	117.8	91.1	71.9	47.8	42.5	31.1	5.2	5.2	0	0
balance-sheet.row.total-equity	58924.27	14766.7	14936.3	14311	13640.1	12275.2	11749.9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	100760.61	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	6824.71	1762.7	1738.2	1694.9	988.1	651.2	595.8	286.1	238.4	248.5	179.2	133.8	131.6	127.8	56.5	61.3	51.8	101	55.5	59	43.1	69.1	61.1	48.7	76.7	41.6	36.3	0	1.3	5.7	11.2	41.7	0
balance-sheet.row.total-debt	16869.38	5036.1	3618.7	2694.4	1929.9	1360.8	1501.1	1.1	1.1	651.1	842.8	1041.4	537.3	252.9	344.7	309.7	631.8	491.1	691.4	594.8	538.4	517.5	254.7	302.2	224.3	194.7	219.3	191.8	312.9	201.1	109.9	104.8	227.9
balance-sheet.row.net-debt	-26792.9	-6289.6	-6792.6	-6452	-8023.8	-7494.6	-7086.8	-7414.7	-2060.8	-147.2	127.1	280.3	-684.1	-1194.8	-519.3	-278.8	91.6	208.4	407.5	465.3	234.9	93.4	-40.6	69.4	114.3	42.1	174.4	115.5	223.9	164	59	53.4	147.8

现金流量表

在 Livzon Pharmaceutical Group Inc. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 0.404 的转变。该公司最近通过发行 -23.55 扩大了股本，与上一年相比出现了-1.241 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-777111530.000. 与上一年相比， -0.368 发生了变化. 在同一时期，公司记录了 866.38, -23.6 和 -531.84，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-1487.56 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 -407.99，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	1979.57	1953.7	1955.5	1952.1	2131.3	1461.6	1181.7	4487.7	829.9	659.6	553.6	524	475.2	387.8	452.5	513.8	72.9	523.4	149.3	116.3	134.7	121.5	86.3	74.7	25.9	9	40.8
cash-flows.row.depreciation-and-amortization	-39.81	866.4	652.3	445.3	394.3	384.6	364.1	359.2	362.1	310.9	247.1	168.9	152	141	120.9	126.9	131.9	122.5	105.6	96.8	75.8	83.6	71.4	76.1	51.7	39.3	32.1
cash-flows.row.deferred-income-tax	-369.4	-13.4	2.4	15.5	-39.4	-21	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	113.77	-1716.6	47.3	32.7	31.4	16.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	208.59	16.2	-121.6	-653.2	-406.6	-197.1	-371.5	823.2	-64	-203	-180.2	-308.4	-84	111.2	52.2	-144.2	-133.3	-105.2	-30.7	-49.2	-15.9	56.1	-4.2	-75.7	-44	119.8	-77.3
cash-flows.row.account-receivables	466.29	466.3	-660.5	-664.7	-491.9	-81.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-334.42	-334.4	-498.6	-232	-400.3	-108.3	-97.1	-44.9	-182.1	-196.6	-270.8	-135.3	-140.1	14.6	-116.7	-1.2	-32.6	-51.7	-53.6	-24.8	10.6	11.3	-5.7	23.1	-10.5	11.6	2.8
cash-flows.row.account-payables	0	-115.7	1035	228	525	13.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	76.73	0	2.4	15.5	-39.4	-21	-274.4	868.1	118.1	-6.4	90.6	-173.1	56.1	96.5	168.8	-143	-100.7	-53.5	22.9	-24.5	-26.4	44.8	1.5	-98.8	-33.5	108.3	-80.1
cash-flows.row.other-non-cash-items	2098.71	2288	236.7	109.9	49.6	122.4	93.3	-4354.2	151.2	160.3	96.9	55.5	50.8	68.3	7.8	-1.6	273.7	-292.1	2.2	-2.7	-13.2	38.9	60.1	80.1	4.9	78.1	-13.9
cash-flows.row.net-cash-provided-by-operating-activities	3954.38	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-829.66	-820.5	-940.1	-1309.1	-647	-398	-474.5	-294.2	-368.5	-477.1	-665.5	-920	-762.3	-348.8	-337	-131.4	-75.5	-91.3	-180.4	-256.7	-146.5	-103.6	-103.6	-81.5	-61.5	-73.4	-31.7
cash-flows.row.acquisitions-net	41.9	68.5	3	3.3	5.3	1.9	24.7	4479.9	78	7	2.8	0.2	762.6	349.5	344.6	-7	-71.3	95.5	224.8	10	11.8	8	2.4	9	0	7.9	0.7
cash-flows.row.purchases-of-investments	-774.52	-473.2	-399.2	-786	-129.2	-126.1	-556	-188.7	-672.6	-80.8	-93.3	-0.5	-151.5	-75.3	-2.4	0.7	-18.2	-430.4	-447.8	-152.5	-281.6	-268.4	-23.3	-63.9	-33.9	-32.1	-2.6
cash-flows.row.sales-maturities-of-investments	451.25	471.6	130.7	208.7	273.3	136.1	37	674.3	1.2	0.5	14.3	47.4	18	1.2	1.2	146.7	133.8	503.1	447.8	178.2	251.3	96.5	15.1	20.4	0.3	10.1	16.2
cash-flows.row.other-investing-activites	-27.71	-23.6	-24.2	6.2	29.7	70.1	-52.2	1.3	18.6	-7.9	3.6	-1.7	-762.3	-348.8	-337	5	11.2	-91.3	-180.4	-0.5	0	-0.6	0.8	0.6	-0.6	-0.2	1.8
cash-flows.row.net-cash-used-for-investing-activites	-1138.74	-777.1	-1229.9	-1876.9	-467.8	-316	-1020.8	4672.7	-943.2	-558.4	-738	-874.6	-895.5	-422.3	-330.5	14	-20	-14.4	-136.2	-221.5	-165	-268	-108.5	-115.5	-95.7	-87.8	-15.6
cash-flows.row.debt-repayment	-2442.86	-531.8	-2804.8	-2033.6	-1829.8	-1650	-300	-350	-1510	-1242	-1167.4	-1235.2	-620.8	-311.6	-414.6	-929.4	-1166.7	-1044.8	-1100.5	-821.7	-1024.5	-518.3	-605.8	-262.4	-285.2	-295.1	-304.1
cash-flows.row.common-stock-issued	-23.55	-23.5	56	238.2	250.1	0	637.6	15	1518.3	298.9	98	51.5	0	0	9.8	0.4	0	0	0	0	0	0	34.1	0.1	5.7	0	0
cash-flows.row.common-stock-repurchased	-346.15	-346.2	-56	-238.2	-250.1	0	0	-64	-352.4	414.6	1149.8	1295.5	0	0	436.2	594.5	0	0	0	0	0	0	536.4	340.4	308.6	0	0
cash-flows.row.dividends-paid	-1581.51	-1487.6	-1299.9	-1257.4	-1100	-868.5	-1120.7	-216.3	-231.1	-83.4	-199.3	-192.3	-185.3	-37.1	-55.9	-51.7	-192.6	-33.6	-42.8	-63.8	-42.8	-76.8	-44.2	-26	-22	-39.2	-22.6
cash-flows.row.other-financing-activites	2322.69	-408	3384.4	2475.9	2411.8	1337.4	1640.5	32.1	1514	297.1	98	88.2	853.2	652.8	10.4	-104.8	1295.9	845.4	1207.5	773.6	930.1	692.1	36.6	0.4	7.7	285	329.1
cash-flows.row.net-cash-used-provided-by-financing-activities	-2665.47	-1733.4	-720.4	-815	-518	-1181.1	857.4	-583.1	938.8	-314.9	-20.9	7.8	47.2	304.1	-14.1	-490.9	-63.4	-233	64.2	-111.9	-137.2	97	-43	52.5	14.7	-49.2	2.4
cash-flows.row.effect-of-forex-changes-on-cash	43.17	20	124.9	-37.2	-77	20.4	58.5	-66.4	20.1	3.5	-0.3	-0.9	0.8	-2.3	-2.5	0.2	-2.8	-3.7	-0.2	-1.7	0.1	-0.1	0	0	0	0	0
cash-flows.row.net-change-in-cash	176.59	914.4	947.3	-826.7	1097.9	290.5	1162.7	5339.1	1294.8	58	-41.8	-427.7	-253.5	587.7	286.2	18.1	259	-2.6	154.4	-174	-120.6	128.8	62.1	92.1	-42.5	109.2	-31.4
cash-flows.row.cash-at-end-of-period	42594.48	11325.7	10072.6	9125.3	9952	8854.2	8563.7	7401	2061.9	767.1	709.1	750.9	1178.6	1432.2	844.5	558.3	540.2	281.2	283.9	129.5	303.5	424.1	295.3	232.8	110	152.5	44.9
cash-flows.row.cash-at-beginning-of-period	42417.89	10411.3	9125.3	9952	8854.2	8563.7	7401	2061.9	767.1	709.1	750.9	1178.6	1432.2	844.5	558.3	540.2	281.2	283.9	129.5	303.5	424.1	295.3	233.1	140.7	152.5	43.3	76.3
cash-flows.row.operating-cash-flow	3954.38	3394.2	2772.7	1902.3	2160.8	1767.2	1267.6	1315.9	1279.2	927.8	717.4	440	594	708.2	633.3	494.9	345.2	248.6	226.5	161.1	181.5	300	213.6	155.1	38.5	246.2	-18.2
cash-flows.row.capital-expenditure	-829.66	-820.5	-940.1	-1309.1	-647	-398	-474.5	-294.2	-368.5	-477.1	-665.5	-920	-762.3	-348.8	-337	-131.4	-75.5	-91.3	-180.4	-256.7	-146.5	-103.6	-103.6	-81.5	-61.5	-73.4	-31.7
cash-flows.row.free-cash-flow	3124.72	2573.8	1832.5	593.2	1513.8	1369.2	793.1	1021.7	910.8	450.7	51.9	-480	-168.3	359.4	296.3	363.5	269.7	157.3	46	-95.6	35	196.5	110	73.7	-23	172.8	-50

利润表行

Livzon Pharmaceutical Group Inc. 的收入与上期相比变化了 -0.028%。据报告, 000513.SZ 的毛利润为 7356.6。该公司的营业费用为 5434.76，与上年相比变化了 -8.412%. 折旧和摊销费用为 866.38，与上一会计期间相比变化了 -0.065%. 营业费用报告为 5434.76，显示-8.412% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长-0.182%. 营业收入为 1921.84，与上年相比变化了-0.182%. 净利润的变化率为 0.023%。去年的净收入为1953.65.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1991
income-statement-row.row.total-revenue	12223.18	12278.5	12629.6	12063.9	10520.4	9384.7	8860.7	8531	7651.8	6620.5	5544.2	4618.7	3943.5	3162.9	2726.7	2595.8	2058.6	1748.1	1510.1	1626.1	1554.8	1811.9	1601.2	1395.8	1178.6	1133.8	899	822.2	721.1	682.7	600.1	699.7	695.9
income-statement-row.row.cost-of-revenue	4437.01	4921.9	4461.3	4253.1	3673.7	3391.7	3359.7	3083.1	2747.8	2575.3	2142.9	1694.6	1569.7	1397.9	1286.5	1232	1116.3	973.6	806	906.2	791.5	914.6	894.5	741.4	634.8	622.8	580.3	526.1	475.6	466.5	423.9	571.8	578.5
income-statement-row.row.gross-profit	7786.18	7356.6	8168.3	7810.8	6846.7	5993	5501	5447.9	4904	4045.2	3401.3	2924.1	2373.8	1765	1440.2	1363.9	942.3	774.5	704	719.9	763.3	897.3	706.7	654.4	543.8	511	318.8	296.1	245.6	216.2	176.1	127.9	117.4
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	1201.39	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	697.3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	3509.36	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-220.47	-291	-36.9	351.7	318.2	320.4	142.4	68.6	130.2	121.1	68.9	38.6	42.6	33.6	18.1	7.4	7.9	6.9	-28.6	3.1	2.7	4.6	13.1	7.5	3.4	20.7	56	33	29.4	16.2	9.4	1.4	-0.6
income-statement-row.row.operating-expenses	5579.94	5434.8	5933.9	5623.1	4531.7	4408	4396	4236.2	3915.3	3229	2741.9	2306.6	1847.2	1309.3	922.8	788.7	579.5	463.5	546.8	588	633.2	755.7	572.2	546.7	477.4	511.4	306.1	246.3	181.5	139.2	85.3	52.3	41.3
income-statement-row.row.cost-and-expenses	10016.94	10356.7	10395.2	9876.2	8205.4	7799.7	7755.6	7319.3	6663.1	5804.3	4884.8	4001.2	3416.9	2707.2	2209.3	2020.7	1695.8	1437.2	1352.8	1494.2	1424.7	1670.3	1466.7	1288.1	1112.2	1134.2	886.3	772.4	657.1	605.7	509.2	624.1	619.8
income-statement-row.row.interest-income	-408.07	-368.2	-315.1	162.2	175.6	226.4	236.2	78.1	9	10.5	13.7	21.9	40.1	42	10.4	5.1	7.5	3.7	2.9	2.5	2.9	7.7	3.5	9.5	3.7	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	102.25	102.1	97.5	84	25.3	7.3	16.8	3.1	27	31.3	26.9	9.1	17.2	22.1	11	17.3	43.9	30.4	33.6	18.7	11.4	10	21.1	14.1	10.3	7.9	12.2	18.3	14.5	18.7	0.9	15.7	16.1
income-statement-row.row.selling-and-marketing-expenses	3509.36	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	123.03	402.4	-20	-21.3	-11	-2.3	311.7	4513.2	16.4	-8.3	-7.4	11.4	33.7	7.4	16.2	14.3	-257.2	309	22.4	-2.6	19	10.4	-38.2	-19.4	-34.6	16	48.3	19.8	32.9	10.7	19.8	-13.6	-16.7
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-220.47	-291	-36.9	351.7	318.2	320.4	142.4	68.6	130.2	121.1	68.9	38.6	42.6	33.6	18.1	7.4	7.9	6.9	-28.6	3.1	2.7	4.6	13.1	7.5	3.4	20.7	56	33	29.4	16.2	9.4	1.4	-0.6
income-statement-row.row.total-operating-expenses	123.03	402.4	-20	-21.3	-11	-2.3	311.7	4513.2	16.4	-8.3	-7.4	11.4	33.7	7.4	16.2	14.3	-257.2	309	22.4	-2.6	19	10.4	-38.2	-19.4	-34.6	16	48.3	19.8	32.9	10.7	19.8	-13.6	-16.7
income-statement-row.row.interest-expense	102.25	102.1	97.5	84	25.3	7.3	16.8	3.1	27	31.3	26.9	9.1	17.2	22.1	11	17.3	43.9	30.4	33.6	18.7	11.4	10	21.1	14.1	10.3	7.9	12.2	18.3	14.5	18.7	0.9	15.7	16.1
income-statement-row.row.depreciation-and-amortization	372.3	866.4	926.6	588.1	474.4	445.9	364.1	359.2	362.1	310.9	247.1	168.9	152	141	120.9	126.9	131.9	122.5	105.6	96.8	75.8	83.6	71.4	76.1	51.7	39.3	32.1	12.2	-3.5	3.4	-15.5	14.5	16.1
income-statement-row.row.ebitda-caps	2729.85	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	2357.55	1921.8	2350.6	2267	2500.4	1729.9	1274.5	5657.8	876.5	692.8	584.5	590.6	518.8	429.7	516.4	583.3	99.6	613.8	218.4	131.7	157.6	158.8	113.7	107.9	35.3	-2.4	9	37.6	67.5	73.6	106.3	61.1	60
income-statement-row.row.income-before-tax	2480.58	2324.2	2330.6	2245.7	2489.4	1727.5	1416.7	5724.9	1005.1	807.9	652	628.9	560.3	463.2	533.7	589.4	105.7	620	184.7	132.1	154.7	157.7	111.6	101.9	35.3	17	63	70.1	96.9	88.8	113.2	62.2	59.4
income-statement-row.row.income-tax-expense	491.85	485.1	375	293.6	358.1	266	235	1237.2	175.1	148.4	98.4	105	85.1	75.4	81.2	75.6	32.7	96.6	35.4	15.8	19.9	36.2	25.3	27.2	9.4	7.9	15.9	15.5	10.3	7.7	10.3	3	1.6
income-statement-row.row.net-income	1979.57	1953.7	1909.4	1775.7	1714.9	1302.9	1082.2	4428.7	784.4	622.6	516	487.5	441.7	359.4	418.2	481.6	52.1	508.5	139.1	107.9	124.1	92.2	61.9	50.4	10.4	1.6	40.8	43.2	81.4	80.2	101.1	59.2	57.8